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Differential diagnosis between keratoacanthomas and well differentiated squamous cell carcinomas based on clinical and
histomorphological data is problematic. Recent ﬁndings of cellular atypia in a large proportion of keratoacanthomas indicated
that these potentially ‘self-healing’ cutaneous neoplasms had the potential for malignant progression. Another malignancy-
associated criterion is enhanced angiogenesis with increased microvessel density. To provide further diagnostic markers for
keratoacanthomas we examined microvessel density on parafﬁn sections of 13 keratoacanthomas in comparison with 10
normal skin biopsies and 16 late-stage skin squamous cell carcinomas by counting and by computer-assisted image analysis of
CD31-immunostained vessels. A signiﬁcant increase of microvessel density in ‘hot spots’ was observed in keratoacanthomas as
compared to normal skin. Furthermore, when keratoacanthomas were subdivided into tumours with and without malignancy-
associated atypic areas, only those with atypia (n=6) were signiﬁcantly better vascularised than normal skin and had a mean
microvessel density in the range of late-stage squamous cell carcinomas. Both keratoacanthoma subtypes revealed comparable
levels of inﬂammatory cell inﬁltration, tumour cell proliferation and vascular endothelial growth factor expression (mRNA and
protein). Thus, in addition to malignancy-associated cellular atypia, increased microvessel density may serve as further
diagnostic parameter to discriminate keratoacanthomas with a potential to progress to malignancy.
British Journal of Cancer (2002) 87, 1301–1307. doi:10.1038/sj.bjc.6600622 www.bjcancer.com
ã 2002 Cancer Research UK
Keywords: angiogenesis; keratoacanthoma; atypia; vascularisation; VEGF
Keratoacanthoma (KA) is a cutaneous squamous neoplasm arising
preferably from hair follicle cells on sun-exposed skin (Schwartz,
1994). First described in 1950 by Rook and Whimster as a rapidly
growing but self-healing skin tumour its differential diagnosis and
its dignity has been disputed for a long time (Rook and Whimster,
1979). This is also notable in the various nomenclature ranging
from ‘tumourlike keratosis’ or ‘self healing epithelioma’ to ‘self
healing squamous cell carcinoma’ (for review see Schwartz,
1994). However, in contrast to low grade variants of squamous cell
carcinoma (SCC), KAs clinically present with a rapid growth phase
for the ﬁrst 4–8 weeks and a possible spontaneous self-induced
regression after 3–6 months. So, clinically, there are three stages
of KA: the proliferative stage, the mature/fully-developed stage
and the involutional stage (Schwartz, 1994). Due to its similarity
in growth rate and morphology to rapidly growing well differen-
tiated SCCs (Billingsley et al, 1999) some authors believe it is a
well-differentiated variant of cutaneous SCCs (Manstein et al,
1998) or at least an ‘abortive malignancy, which only rarely
progresses into SCC’ (Schwartz, 1979).
Cells of KAs harbour similar genetic changes as malignant SCCs,
for example mutations in the p53-tumour suppressor gene
(Kerschmann et al, 1994) or an activated ras-oncogene (Corominas
et al, 1991). Using ﬂow cytometry analysis, neither DNA content
nor the proliferative index discriminated SCCs from KAs (Randall
et al, 1990). But recent studies on the genetics of epithelial skin
tumours reveal multiple differences in loss of heterozygosity
between KAs and SCCs (Waring et al, 1996).
Immunohistochemically there is no deﬁnite means to distin-
guish between SCCs and KAs. Merely different patterns of
distribution of involucrin (Smoller et al, 1986) and proliferation
markers as PCNA (Phillips and Helm, 1993) or Mib-1 (Skalova
and Michal, 1995) have been described. Recently, different patterns
of immunohistochemical staining of desmoglein-1 and -2 as
markers for desmosomes have been observed indicating that a loss
of desmosomes is predominantly observed in SCCs and not in KAs
(Krunic et al, 1998). This is in accordance with earlier ultrastruc-
tural studies claiming larger intercellular spaces and a loss of
desmosomes in SCCs as a main feature distinguishing KAs from
SCCs (Miracco et al, 1992).
Nevertheless, differential diagnosis remains critical (Cribier et al,
1999) and therefore has to be based on both clinical history and
common histologic criteria, especially the lack of invasion into
the dermis.
More recently, there have been new data that stress the impact
of atypia on clinical presentation and prognosis of KAs (Sanchez
et al, 2000). The authors even found in about one third of KAs
areas with cellular and nuclear atypia indicative of malignant trans-
formation and thus support the hypothesis that those KAs of
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patients may progress to malignant SCCs.
Another hallmark of malignant tumours is the induction of
persistent angiogenesis with its consequence of increased vessel
density in the tumour stroma. Malignant tumours critically depend
on angiogenesis for continued growth, invasion, and formation of
metastases (Folkman, 1995). Accordingly, malignant epithelial skin
tumours such as SCCs reveal signiﬁcantly higher microvessel
density (MVD) than perilesional skin (Weninger et al, 1997).
Moreover, in skin SCCs the angiogenic switch occurs not until
late-stage tumours penetrate deeper into the dermis and have a
higher metastatic risk, so that vascular density appears to be of
prognostic signiﬁcance (Strieth et al, 2000). On the other hand,
increased MVD has also been detected in KAs (Weninger et al,
1997) and in hyperproliferative lesions such as psoriasis (Detmar
et al, 1994). In all these hyperproliferative stages of the epidermis,
including normal wound healing, the vascular endothelial growth
factor (VEGF) is considered a major inducer of angiogenesis,
because it is overexpressed in those epithelia (Brown et al, 1992;
Detmar et al, 1994; Weninger et al, 1996).
We have shown earlier that VEGF expression was similar in
premalignant lesions (actinic keratosis) as well as in early- and
late-stage malignant skin SCCs, although MVD was signiﬁcantly
elevated in late stage SCCs only (Strieth et al, 2000). Strong VEGF
expression had been observed both in SCCs and KA as well as in
adjacent normal epidermis and was therefore considered not a
valid criterion to distinguish malignant from benign epithelial skin
tumours (Weninger et al, 1996).
In the present study we have analysed MVD in KA with (mKA)
and without (nKA) cellular atypia (Sanchez et al, 2000). While
MVD correlated neither with inﬂammatory cell inﬁltration, rate
of tumour cell proliferation nor VEGF expression, increased
MVD was restricted to mKAs and equalled MVD in late-stage
SCCs (Strieth et al, 2000) thus supporting malignant progression.
MATERIALS AND METHODS
Patients and material
Formalin-ﬁxed, parafﬁn-embedded specimens from 13 patients
with KAs were analysed. These tissue specimens were derived for
therapeutic purposes with fully informed consent of patients and
were compared with 10 normal skin biopsies of comparable anato-
mical locations exhibiting no histopathological alterations. All cases
were located in sun-exposed areas of the skin predominantly in the
face (61.5%).
Identiﬁcation of mature-stage KAs
H&E-stained sections of the parafﬁn-embedded blocks were exam-
ined and the diagnosis of mature, non-involuting KA was
conﬁrmed by a dermatopathologist not involved in the analysis
of vascularisation.
A high degree of differentiation often exhibiting large spinous
cells with eosinophilic ‘glassy’ appearance of the cytoplasm, a
central keratinous core with overhanging epithelial ‘lips’ resulting
in a symmetric tumour architecture at low magniﬁcation and
essentially a lack of invasion into the subcutis were mandatory
for the diagnosis of mature-stage KAs (Schwartz, 1994).
Central keratinisation of KAs was not used to further subdivide
into bud-, dome- or berry-shaped subtypes.
There were no special morphologic (e.g. ‘agglomerate’; ‘centrifu-
gum’; ‘giant’; etc.) or syndromic (e.g. Ferguson-Smith-S.- or Muir-
Torre-S.-associated) types of KA among the specimens (for review
see Schwartz, 1994).
After the completion of vascular density assessment (see Materi-
als and Methods) the group of KA was further subdivided by a
pathologist not involved in MVD analysis in (normal) KAs without
atypia (nKA, n=7) and KAs with cellular and nuclear atypia as a
sign of malignant transformation (mKA, n=6): mKAs were charac-
terised by the coincidence of atypical cells that can also be found in
SCCs and remnants of typical well differentiated KA cells, respec-
tively. In these lesions symmetry of tumour architecture was
partially altered. But in contrast to SCCs no frank invasion was
detectable on serial sections neither in nKAs nor in mKAs. Other
features as actinically damaged elastic ﬁbers or intraepithelial
microabscesses were observed in some specimens, but were not
included for the diagnosis or classiﬁcation.
In addition to these histopathological criteria clinical data were
used for diagnosis (Schwartz, 1994).
Endothelial cell identiﬁcation by CD 31
immunohistochemistry
Sections (5 mm thick) were cut from the retrieved tumour blocks,
dewaxed and rehydrated in graded ethanol. Endogenous peroxidase
was blocked with 0.3% H2O2 for 15 min. To unmask hidden
epitopes, sections were digested with protease type XXIV
(10 mg ml
71; Sigma, Deisenhofen, Germany) at 378C for
15 min. Vessels were visualised by immunostaining with a mono-
clonal antibody against CD31 (clone JC70/A; Dako, Glostrup,
Denmark). Sections were incubated for 6 h (the optimal time) with
the primary antibody diluted 1:40 in PBS and subsequently devel-
oped using a streptavidin-biotin-peroxidase system (Amersham,
Braunschweig, Germany). Visualisation of the antibody complex
was achieved with a nickel-enhanced diaminobencidin reaction
(Hsu and Soban, 1982) resulting in black staining of endothelial
cell membranes. Sections were counterstained by a modiﬁed
Masson-Goldner protocol omitting hematoxylin, as described
(Strieth et al, 2000).
Quantitation of vessel density
Sections were screened at a magniﬁcation of 1006 for areas of
highest microvessel density, so-called ‘hot spots’ (Weidner et al,
1991) and three of such areas were analysed per section. While
focusing on the margins of epithelial tissues, areas next to hair
follicles and glands were avoided. At a magniﬁcation of 2006
the black stained vessels were counted in a square grid deﬁning
an area of 0.09 mm
2 (3496264 mm). All black stained single cells
or clusters of cells which were separated from other stained areas
were counted as single vessels. Vascular density was deﬁned as
the mean vessel count of three areas analysed per section. Results
obtained from different sections of the same tumour showed a
repetitive pattern (data not shown). Additionally, vessel density
was determined by computer-assisted image analysis in the same
grid-deﬁned area used for the manual count at a magniﬁcation
of 2006 using a Leica Quantimet 600QWin-Image Analysis System
(Leica, Wetzlar, Germany) equipped with a 3CCD camera. The
black stained vessels were detected automatically using the Hue-
Saturation-Intensity (HSI) system. In cases where interference
was observed with other dark material such as erythrocytes or horn
material, this was corrected interactively. Vascular density was
calculated as the mean of three measurements per section, and
plotted as percentage of stained area (% area).
Assessment of inﬂammatory cell inﬁltrate
On parallel H&E-stained sections inﬁltration of inﬂammatory
cells was assessed without discriminating white blood cell
subtypes. Cell density was screened by a pathologist not involved
in determining vessel density and classiﬁed as ‘no inﬁltration’,
‘low degree’, ‘intermediate degree’, and ‘strong degree of inﬁltra-
tion’.
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Parallel sections of six KAs without atypia (nKA) and four KAs
with atypia (mKAs) were analysed for proliferating cells by immu-
nostaining with the monoclonal antibody Mib-1 (Ki67; Dianova,
Hamburg, Germany) after 30 min microwave incubation and using
the same immunohistochemical method (DAB-nickel) as for the
identiﬁcation of endothelial cells. The ratio of proliferating to
non-proliferating cells in tumour tissue was assessed as described
(Kerschmann et al, 1994).
In situ hybridisation of VEGF-RNA
Human cDNA (649 bp) encoding human VEGF165 in Bluescipt
KS
7 vector (Stragagene, La Jolla, CA, USA) (Keck et al, 1989),
generously provided by Drs H Weich and D Marme ￿ (Freiburg,
Germany) was used as a probe. In situ hybridisation was essentially
performed as described (Moorman et al, 1993). In brief,
35S-
labelled RNA probes for VEGF were prepared using T3 and T7
RNA-polymerase (for antisense and sense probes, respectively)
according to the manufacturer’s instructions (Roche Diagnostics,
Mannheim, Germany). Parafﬁn sections of normal skin (n=3)
and KAs (two nKA and one mKA), parallel to those used for deter-
mining vascular density, were pretreated, hybridised and washed at
high stringency as described (Strieth et al, 2000). For autoradiogra-
phy, slides were coated with NTB2 ﬁlm emulsion and exposed for
4 weeks. After the ﬁlm was developed, sections were counterstained
with hematoxylin.
VEGF immunohistochemistry
Indirect immunohistochemistry using a polyclonal antibody
against VEGF165 (1:20; Cat.No. GF 25; Calbiochem, San Diego,
CA, USA) was performed on sections of both KA subtypes paral-
lel to those specimens used for in situ hybridisation and on
additional sections of nKA and mKA cases. Pretreatment of
sections was performed by a 30 min incubation in 0.05% Sapo-
nin (Sigma, Deisenhofen, Germany). Background staining was
blocked by incubating the slides 15 min in streptavidin
(1 mgm l
71; Sigma, Deisenhofen, Germany) and normal goat
serum (1:10; Dianova, Hamburg, Germany) before application
of the primary antibody. The secondary antibody was diluted
in PBS with 5% human serum (Dianova, Hamburg, Germany).
To test the speciﬁcity of antibody staining, recombinant VEGF165
(E. coli), kindly provided by Dr D Marme ￿ (Freiburg, Germany),
was used for neutralising the antibody as negative control
(ligand: antibody=9.7:1, based on protein mass) and led to
complete abrogation of the antibody reactivity. Evaluation of
RNA and protein expression of VEGF was based both on area
and intensity of the staining.
Statistical analysis
The mean vascular area percentage and the mean manual vessel
count data have been calculated with the MS Excel software. Data
are presented as boxplots or are given as mean+s.d. and have been
further analysed by the statistics software Sigmastat (SPSS Inc.,
Chicago, IL, USA). Linear regression and calculation of Spearman’s
correlation coefﬁcient was performed to test correlations between
different vascular density parameters, inﬂammatory scores and
proliferative rates. The Mann-Whitney U-test was used to test
differences in vascular density values (% area) between normal skin
and KAs and differences in age of nKA and mKA patients, respec-
tively. In addition, vascular density values of nKAs and mKAs were
compared to those of normal skin and late-stage SCCs reported
earlier (Strieth et al, 2000) using the Kruskal-Wallis one way analy-
sis of variance on ranks and Dunn’s all pairwise multiple
comparison procedure as post hoc analysis. P values less than
0.05 were considered signiﬁcant.
RESULTS
Clinical data analysis of KA patients
Mature stage KAs were diagnosed according to clinical history and
common histopathological criteria as described above (Figure
1A,B). Nearly all lesions were located in sun-exposed skin, most
of them (n=8; 61.5%) in the head and neck region, two on arms,
two on legs and one on the back. Localisations of the lesions had
no signiﬁcant inﬂuence on their vessel density (data not shown).
All were primary lesions and no basic disease (e.g. diabetes mellitus
or psoriasis) was evident in KA patients which might have affected
the degree of vascularisation.
Evaluation of durations of the lesions in nKA patients, as
compared to mKA patients was difﬁcult because these clinical data
were only available in less than 50% of the cases. Therefore no
statistical analysis was performed. A tendency to increased dura-
tions in mKA patients (nKA: 0.9+0.4 months vs mKA: 3.2+2.0
months) must not be ovestimated because it was essentially due
to one mKA lesion noticed by the patient for 6 months before diag-
nosis.
Immunohistochemical detection of blood vessels
Reaction of antibodies against CD31 provided an uniform and
intense membrane staining of endothelial cells lining smaller and
larger vessels with no or very low background. Using the nickel
enhancement procedure endothelial cells forming the walls of
vessels of all sizes were easily identiﬁed and even very small vessels
clearly recognised (Figure 1E). The marked vessels were counted
and the density of the stained area morphometrically assessed in
three framed areas per section choosing ‘hot spots’ of vascular
density. In control sections of anatomically related normal skin,
a typical capillary bed of normal, uninﬂamed and non-irritated
dermis was visible. In areas adjacent to tumour cell nests vascular-
isation of KAs appeared clearly increased compared to normal skin
(Figure 1D).
Quantitative assessment of vascularisation in KAs
In order to quantitate vascularisation of KAs, MVD was assessed in
tumour stroma both by manual count and computer-assisted
morphometric analysis of stained areas in at least three regions
of interest on each tumour section. When comparing both quanti-
tation methods in tumour and normal skin sections, respectively,
the data were very well correlated (Spearman’s correlation coefﬁ-
cient: 0.86; Figure 2). For comparison with normal skin and
SCC, respectively, data obtained by morphometrical analysis of
stained vessel area were used. When compared to normal skin,
vascular density in the tumour-adjacent stroma of all KAs was
more than twice higher and this was highly signiﬁcant (P50.001;
Figure 3).
However, upon subdividing the group of KAs (n=13) in KAs
without atypia (nKAs, n=7, Figure 1C) und KAs with atypia
(mKAs, n=6, Figure 1D) only mKAs were signiﬁcantly better
vascularised than normal skin (P50.05; Figure 3).
In order to directly compare SCCs, nKA and mKAs, late-stage
SCC vascular density values obtained from an earlier study are
depicted in Figure 3 (Strieth et al, 2000). Considering the present
debate of a potential malignant transformation of KA with atypia
into an invasive tumour it was intriguing that vascular density in
mKAs – but not nKAs – was comparable or even higher than
in invasive late stage SCCs (Figure 3). Although nKAs still exhib-
ited increased vascularisation, as compared to normal skin, this
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Figure 1 Two subtypes of keratoacanthoma: (A) nKA revealing neither cellular nor nuclear atypia (H&E). (B) mKA showing prominent cellular and nu-
clear atypia of tumour cells (H&E). Immunohistochemical staining of microvessels using CD31-antibodies in KA. (C) nKA (counterstaining modiﬁed Masson-
Goldner). (D) mKA, ‘hot spot’ in frame (t: tumour). (E) Endothelial staining in detail. VEGF expression: (F) VEGF protein localisation by immunohistochem-
istry in KA revealed a distribution with preference to differentiating cells. (G) Expression of VEGF-RNA revealed by radioactive in situ hybridisation in KA.
VEGF anti-sense probe (dark ﬁeld). (H) Corresponding sense probe control (dark ﬁeld). Bar: 30 mm.
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stage SCCs.
Impact of chronic inﬂammatory cell inﬁltrates and tumour
cell proliferation
Changes in vascular density might have been caused by inﬂamma-
tory reactions in the tumour stroma or simply associated with
higher proliferation rates of the tumour cells. Therefore, the extent
of inﬂammatory cell inﬁltration was assessed in H&E-stained
sections at a magniﬁcation of 2006 using an arbitrary scale for
the frequency of white blood cells, mainly lymphocytes. While
inﬂammatory cells were absent in normal skin specimens, they
were frequent in KAs. Three tumours (one nKA and two mKAs)
revealed a ‘low degree’ of inﬂammatory cell inﬁltrate, while the
majority of KAs (four nKAs and four mKAs) showed an ‘inter-
mediate degree’ of inﬂammation. Only two tumours, and these
were both nKAs, exhibited an inﬂammatory response considered
as ‘strong’. Summarised, there is neither a correlation between
these inﬂammatory cell inﬁltrates and vascular density values in
individual KA lesions (P=0.24) nor in the groups of nKAs
(P=0.92) and mKAs (P=0.25), respectively. This documented that
the different vascular density values in KAs were not signiﬁcantly
affected by inﬂammatory cell inﬁltrates.
The rate of proliferating (Mib-1 positive) epithelial cells was
determined in 10 tumours (six nKAs and four mKAs) and seven
control specimens of normal skin. All KAs revealed high prolifera-
tion rates (48+8%) as compared to normal skin (510%), but
there was no difference observed between nKAs (49+4%) and
mKAs (47+12%), respectively. Also, individual tumours with
highest vascular density values did not exhibit the highest prolifera-
tive activity and both parameters were not correlated (P=0.65).
Thus, neither inﬂammatory response in the stroma nor the prolif-
eration rates of tumour cells were obviously responsible for the
increased vascular density observed in mKAs.
Expression of VEGF-RNA and -protein
In order to evaluate whether elevated levels of expression of a
major angiogenesis inducing factor, i.e. VEGF, might have caused
the increased vascularisation in KAs, mRNA expression and protein
levels of VEGF were analysed in parallel sections.
By radioactive in situ hybridisation strong VEGF expression in
epithelial tumour cells was detected in both nKA and mKA (one
nKA, two mKAs; Figure 1G,H). In epidermis of normal skin,
respectively, the expression was also apparent but weaker (data
not shown). There was no signiﬁcant intertumoural variability of
the labelling. Label was observed in all epithelial cell layers, though
with a tendency to more intensity in differentiated cell layers. The
sense probe only yielded some background labelling (Figure 1H).
In addition, VEGF-protein was identiﬁed by indirect immuno-
histochemistry in parallel sections of the same KAs and on
additional sections from each group (nKA: n=2 and mKA: n=4).
There was no obvious difference in staining intensity between
nKAs and mKAs and the staining pattern in all tumours was very
homogenous again, with higher intensity in differentiated cells
(Figure 1F). In normal skin the protein staining was very weak.
As a control for the speciﬁcity of the antibody, the immunoreac-
tion was abolished following blocking of the antibody with
recombinant human VEGF.
When compared to VEGF-expression (RNA- and protein level)
observed in human skin SCCs as reported earlier (Strieth et al,
2000), there were no apparent quantitative differences in intensity
or localisation identiﬁed to that assessed in KAs.
The data obtained for KA in this study further conﬁrm that
there is neither an obvious association between the expression of
VEGF and atypia in the tumours nor between VEGF expression
and intratumoural vascularisation.
DISCUSSION
Tumourgrowthandmetastasisaredependentonpersistentnewblood
vessel growth (Folkman, 1995), and intratumoural MVD is a signiﬁ-
cant prognostic indicator of tumour progression (for review see
Weidner, 1995). With regard to skin carcinogenesis when premalig-
nant lesions and early as well as late-stage (according to Breuninger
et al, 1990) SCCs were analysed, signiﬁcantly increased MVD, as
compared to normal skin, was only observed in late-stage SCCs
(Strieth et al, 2000). This suggests that increased vascularisation may
have prognostic signiﬁcance for the progression of these tumours.
Accordingly, angiogenesis and MVD in KAs are of particular
interest in view of the heterogeneity of these neoplasms, with a
subgroup resembling initial SCCs (Sanchez et al, 2000). Here we
provide new evidence that changes in MVD, in addition to histo-
logic atypia, discriminate KAs into two subgroups with different
potential of progression to malignancy. This may have prognostic
value for this critical skin lesion.
The relationship between KA and squamous cell carcinoma has
been debated since the concept of KA was proposed in 1950 by
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Figure 2 Linear regression of the two vascular density parameters:
manual count vs % area.
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hypothetical question whether KA is a distinct ‘pseudomalignancy’
or a form of SCC that spontaneously involutes in the majority of
cases but rarely metastasises. So far, there is lack of evidence that
involution of KAs really occurs or at least at what percentage
KAs involute, if left alone (Leboit, 2002). There are even reports
about intravascular and perineural invasion or even lymph node
metastasis (for review see Hodak et al, 1993) Furthermore, tumour
regression is reported for typically malignant tumours of the skin
as well (Barnetson and Halliday, 1997). On the other hand, it is
not clear yet whether and how frequently malignant progression
of KAs to SCCs occurs. Reed (1972) was the ﬁrst to raise this ques-
tion based on his observation that 29% of KAs in his ﬁles had
strong morphologic similarities to SCCs, representing KAs with a
degree of nuclear atypia indistinguishable from that seen in SCC.
Due to the lack of clear diagnostic and prognostic criteria to distin-
guish between KA and SCC, all those tumours are currently
surgically excised (Rinker et al, 2001).
Regarding the dignity of KA the best criterion appears to be
atypia (Leboit, 2002). While KA cells with no discernibly atypical
nuclei are associated with a possibly involuting lesion, aggregations
of cells with anaplastic appearance are found in mKA as well as in
SCCs and thus favour malignant progression.
Recently, in a retrospective study revising 220 crateriform prolif-
erative squamous cell lesions new evidence was found that KA
might progress into SCC (Sanchez et al, 2000). While histologically
29 of these cases turned out to be crateriform SCCs, 144 were diag-
nosed KA without atypia (nKA), but in 47 cases there were signs of
frank histologic and cytologic atypias indicative of malignant trans-
formation. In addition, the authors found that patients with nKA
were signiﬁcantly younger than patients with mKA or those with
SCCs. Moreover, patient history revealed reduced durations of
the lesions in patients with nKA, as compared to mKA. Therefore,
based on these histologic and clinical features, the subtype of atypi-
cal KA with probability to malignant conversion (mKA) was
proposed. In the present study, comprising a rather small number
of KAs, it was surprising that about half of the tumours showed
signs of atypia.
An experimental approach to address the question whether
SCCs develop within KAs was attempted in transgenic rabbits using
cottontail-rabbit-papillomavirus-targeted gene expression of the
EJras oncogene to epidermal keratinocytes (Peng et al, 1999).
One hundred per cent of F1 animals developed KAs on day 3 after
birth and 18% developed SCCs 5 months later. Although the
authors did not ﬁnd direct evidence so far for malignant conver-
sion of KAs into SCCs, the sequential induction of both tumour
types by the same oncogene suggested common transformation
mechanisms. In addition, there are further reports of spontaneous
skin tumour development with histological features both of KA
and SCCs in ageing Long Evans rats (Esfandiari et al, 2002).
The consideration of atypia as a sign of malignant progression
in skin tumours is not restricted to KAs: For example, there were
heterogenous reports about the presence of atypical CD30
+ cells in
lymphomatoid papulosis – another potentially ‘self-healing’ cuta-
neous pseudomalignancy (el-Azhary et al, 1994). For this
typically waxing and waning skin lesion it is well documented that
malignant progression occurs (Drews et al, 2000). It has further
been shown that this skin neoplasm deﬁnitely is a monoclonal
T-cell disorder of atypical CD30
+ cells (Steinhoff et al, 2002) and
that these atypical cells are even functionally linked to malignant
progression (Levi et al, 2000).
There are other examples among skin ‘pseudomalignancies’
where atypia is now associated with a potential to progress, for
example atypical ﬁbroxanthoma (now: superﬁcial malignant histio-
cytoma), regressing atypical histiocytosis (now: anaplastic large cell
lymphoma) and proliferating pilar tumour (regarded as form of
SCC) (Leboit, 2002).
The correlation of an angiogenic phenotype and other hallmarks
of biologic aggressiveness in tumours of the skin is well accepted:
For example, basal cell carcinomas (BCC) showing a higher vascu-
lar density appeared to be more aggressive in terms of deeper local
inﬁltration or formation of distant metastasis compared to low-
vascularised relatively benign BCCs (Staibano et al, 1996). More-
over, it has been found that the angiogenic response
discriminates between cutaneous B-cell lymphomas and B-cell
pseudolymphomas with the malignant variant exhiting increased
MVD (Schaerer et al, 2000). Weninger et al (1997) investigated
MVD in BCCs, SCCs and KAs. While they found a signiﬁcantly
lower vascularisation in BCCs there was no signiﬁcant difference
in MVD between SCCs and KAs. However, in this study, no discri-
mination was made between KAs without or with atypia.
In accordance with the data reported by Weninger et al (1997)
we found that KAs are strongly vascularised tumours. By further
subdividing KAs into lesions with and without atypia we observed
that only mKAs (with atypia) were equally well or even better
vascularised than late-stage SCCs. On the other hand, KAs without
atypia (nKAs) were less vascularised than SCCs and did not signif-
icantly differ from normal skin. This difference in MVD was not
inﬂuenced by histological stages of KA development, because only
mature, i.e. non-involuting lesions had been examined. This is also
evident by the high proliferative activity of tumour cells and
excludes the possibility that involuting KAs with their decreased
angiogenesis and vascular density would have obscured the data.
The expression of VEGF was high in both KA subtypes indicating
that this angiogenic factor did not play a decisive role. Strong VEGF
expression was similarly detected in SCCs and even in premalignant
actinic keratosis, although vascularisation was signiﬁcantly different
in both lesions (Strieth et al, 2000). In general, VEGF is rapidly up-
regulated in different epidermal lesions such as wound healing,
common warts, seborrheic keratoses, skin neoplasias (including
KAs) and also detected in normal epidermis (Weninger et al,
1996). The role of VEGF receptors in skin angiogenesis is less clear
though. Heterotransplant studies of benign and malignant skin kera-
tinocytes on nude mice had demonstrated that the expression of both
VEGFR-1 and -2 paralleled induction of tumour angiogenesis, and it
was coincidentally down-regulated with decreasing vascularisation
(Skobe et al, 1997; and unpublished observations).
Other controlling factors or conditions which might play a role in
tumour angiogenesis in KAs cannot be ruled out. Inﬂammatory cell
inﬁltrates, as less speciﬁc angiogenesis inducers and frequently
observed in epithelial skin neoplasms (Coussens et al, 1999), differed
neither in distinct stages of skin carcinogenesis from actinic keratosis
to SCCs (Strieth et al, 2000) nor in the KA subtypes, and are thus less
likely to be involved in the enhanced angiogenesis in KAs.
In summary, the data presented in this study show a strong
correlation between occurrence of atypia and increased vascular
density in KAs. Although this has to be substantiated in a large
number of tumours, vascular density might be an additional prog-
nostic factor indicating the probability of malignant progression of
KA into SCC.
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